reports
Guided Therapeutics Inc: 1 director
A director at Guided Therapeutics Inc bought 1,615,385 shares at 0.130USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Guided Therapeutics Completes License Agreement with Turkish Distribut...
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has signed a definitive, multiyear license agreement with its Turkish distribution partner ITEM for the manufacture of patented single-patient-use Cervical Guides in Turkey. The production of Cervical Guides in Turkey exclusively for the Turkish market was recommended by the Turkish Ministry of Health to speed adoption of the technology in Tur...
Guided Therapeutics Achieves Regulatory Approval for Sale in India
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP) reported today that the Company received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and as such is “not regulated under the Drugs and Cosmetics Act 1940 and Medical Device Rules 2017 thereunder.” As a result, LuViva can now be commercialized in India. “There are approximately 330 million women who a...
Guided Therapeutics Ships 8 LuViva Devices and 4,500 Single Use Cervic...
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP) reported today record sales for a quarter in Indonesia, with eight LuViva® Advanced Cervical Scans shipped in the fourth quarter of last year. In addition, Indonesia ordered 4,500 single-use Cervical Guides which were shipped along with the LuViva devices. The increase in orders of high-margin Cervical Guides indicates that installed LuViva units are beginning to see greater usage in hospitals and clinics. Based on previous studies and evaluations of LuViva, medi...
Guided Therapeutics Signs Preliminary License Agreement with Turkish D...
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has signed a preliminary license agreement with its Turkish distribution partner ITEM for the manufacture of patented single-patient-use Cervical Guides in Turkey. In return for the license and manufacturing rights for Cervical Guides in Turkey, GTHP will receive fees totaling $3,000,000 in 2018. In addition, ITEM will pay GTHP a roya...
Guided Therapeutics Continues to Grow International Sales with New Ord...
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has received a new order of 4,000 single-patient-use Cervical Guides from its Indonesia distributor and that it has signed a Letter of Intent with DSS Image for potential distribution for India. The Company’s LuViva Advanced Cervical scan is now beginning routine use in Indonesia. The Indonesian distributor has now ordered a total of 1...
Guided Therapeutics Receives Order for 10 LuViva® Advanced Cervical S...
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly at the point of care, today announced it has received an order for 10 additional LuViva® Advanced Cervical Scans for Indonesia. The order brings to 24 the number of LuVivas and more than 7,000 the number of single use Cervical Guides sold to Indonesia. Additional orders of Cervical Guides are expected later this year. LuViva has been...
CORRECTING and REPLACING Guided Therapeutics Announces 1:800 Reverse S...
NORCROSS, Ga.--(BUSINESS WIRE)-- First paragraph, second sentence of release should read: The reverse stock split will be implemented when the market opens on Monday, November 7, 2016 ... (instead of The reverse stock split will be implemented when the market opens on Monday, November 9, 2016). The corrected release reads: GUIDED THERAPEUTICS ANNOUNCES 1:800 REVERSE STOCK SPLIT AND ELIMINATION OF “TOXIC” CONVERTIBLE SECURITIES FROM ITS BALANCE SHEET Guided Therapeutics, Inc. (OTCQB: GTHP) today announced a o...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.